Literature DB >> 11762993

Risk of HIV and other blood-borne infections in the cardiac setting: patient-to-provider and provider-to-patient transmission.

V Puro1, G De Carli, P Scognamiglio, R Porcasi, G Ippolito.   

Abstract

Health care workers (HCWs) face a well-recognized risk of acquiring blood-borne pathogens in their workplace, in particular hepatitis B and C viruses (HBV/HBC) and human immunodeficiency virus (HIV). Additionally, infected HCWs performing invasive exposure-prone procedures, including in the cardiac setting, represent a potential risk for patients. An increasing number of infected persons could need specific cardiac diagnostic procedures and surgical treatment in the future, regardless of their sex or age. The risk of acquiring HIV, HCV, HBV infection after a single at-risk exposure averages 0.5%, and 1-2%, and 4-30%, respectively. The frequency of percutaneous exposure ranges from 1 to 15 per 100 surgical interventions, with cardiothoracic surgery reporting the highest rates of exposures; mucocutaneous contamination by blood-splash occurs in 50% of cardiothoracic operations. In the Italian Surveillance (SIROH), a total of 987 percutaneous and 255 mucocutaneous exposures were reported in the cardiac setting; most occurred in cardiology units (46%), and in cardiovascular surgery (44%). Overall, 257 source patients were anti-HCV+, 54 HBsAg+, and 14 HIV+. No seroconversions were observed. In the literature, 14 outbreaks were reported documenting transmission of HBV from 12 infected HCWs to 107 patients, and 2 cases of HCV to 6 patients, during cardiothoracic surgery, especially related to sternotomy and its suturing. The transmission rate was estimated to be 5% to 13% for HBV, and 0.36% to 2.25% for HCV. Strategies in risk reduction include adequate surveillance, education, effective sharps disposal, personal protective equipment, safety devices, and innovative technology-based intraoperative procedures.

Entities:  

Mesh:

Year:  2001        PMID: 11762993     DOI: 10.1111/j.1749-6632.2001.tb03918.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Hepatitis C virus-infected resident: end of residency, end of career?

Authors:  Carolyn M Dresler; Michael S Kent; Richard I Whyte; Robert M Sade
Journal:  Ann Thorac Surg       Date:  2013-03       Impact factor: 4.330

2.  Inadequate hepatitis B vaccination and post-exposure evaluation among transplant surgeons: prevalence, correlates, and implications.

Authors:  Scott D Halpern; David A Asch; Abraham Shaked; Peter Stock; Emily A Blumberg
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

3.  Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.

Authors:  Alan Neaigus; V Anna Gyarmathy; Maureen Miller; Vera Frajzyngier; Mingfang Zhao; Samuel R Friedman; Don C Des Jarlais
Journal:  Drug Alcohol Depend       Date:  2007-02-07       Impact factor: 4.492

Review 4.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

5.  Summary of recommendations for the prevention of viral hepatitis during travel.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2014-07-10

Review 6.  HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis.

Authors:  Ethan Gough; Mirjam C Kempf; Laura Graham; Marvin Manzanero; Edward W Hook; Al Bartolucci; Eric Chamot
Journal:  BMC Public Health       Date:  2010-12-21       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.